Company Description
Diversified Healthcare Trust is a real estate investment trust, or REIT, organized under Maryland law, which owns medical office and life science properties, senior living communities and other healthcare related properties throughout the United States.
As of December 31, 2024, we owned 367 properties located in 36 states and Washington, D.C. As of December 31, 2024, our owned properties include: 98 medical office and life science properties with approximately 8.0 million rentable square feet; 259 senior living communities, including independent living (including active adult), assisted living, memory care and skilled nursing facilities, or SNFs, with approximately 27,000 living units; and 10 wellness centers with approximately 812,000 square feet of interior space plus outdoor developed facilities.
As of December 31, 2024, we also owned an equity interest in each of two unconsolidated joint ventures that own medical office and life science properties located in five states with an aggregate of approximately 2.2 million rentable square feet.
| Country | United States |
| Founded | 1998 |
| Industry | REIT - Healthcare Facilities |
| Sector | Real Estate |
| Employees | 600 |
| CEO | Christopher Bilotto |
Contact Details
Address: Two Newton Place, 255 Washington Street, Suite 300 Newton, Massachusetts 02458-1634 United States | |
| Phone | 617 796 8350 |
| Website | dhcreit.com |
Stock Details
| Ticker Symbol | DHC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001075415 |
| CUSIP Number | 25525P107 |
| ISIN Number | US25525P1075 |
| Employer ID | 04-3445278 |
| SIC Code | 6798 |
Key Executives
| Name | Position |
|---|---|
| Christopher J. Bilotto | President, Chief Executive Officer and Managing Trustee |
| Adam David Portnoy | Managing Chair of the Board |
| Kevin Brady | Director of Investor Relations |
| David M. Blackman | Director of Acquisition |
| Jennifer Babbin Clark | Secretary |
| Melissa Mccarthy | Manager of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 20, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 20, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 20, 2025 | ARS | Filing |
| Mar 20, 2025 | 8-K | Current Report |
| Feb 26, 2025 | 8-K | Current Report |
| Feb 25, 2025 | 10-K | Annual Report |
| Feb 25, 2025 | 8-K | Current Report |
| Feb 3, 2025 | 8-K | Current Report |
| Nov 18, 2024 | 8-K | Current Report |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |